Atlas Trials

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

RecordFirmDate
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) (NCT06099990)Jiangsu HengRui Medicine Co., Ltd.2023-10-01

Track High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) automatically

Every clearance here is in the API, with alerts when new ones post.